Seerpharma.com.au :: Pharmaceutical Consulting & Training :: Validation, GMP & Compliance UK | Singapore | Korea

   

 

 

Type 2 Diabetes: Treatment

Description: Diabetes mellitus is characterized by two important features: patients typically excrete excess amounts of urine, and the urine contains abnormally high levels of glucose, due to glucose leakage in the kidney. The Greek derivations of the words diabetes and mellitus actually mean "siphon" and "honey," respectively, referring to the hallmark traits of this disease. This course discusses the complications associated with type 2 diabetes and how the disease can be managed with both pharamcological and non-pharmacological treatments.

COURSE OUTLINE
INTRODUCTION
1. Course Information
2. Interface Tour
3. Course Overview

PROGNOSIS
4. Objectives
5. Overview of Diabetes Complications
6. Retinopathy
7. Nephropathy
8. Neuropathy
9. Macrovascular Complications
10. Atherosclerosis Disease
11. Management of Complications: Studies
12. Progress Check

TREATMENT
13. Objectives
14. Management of Diabetes
15. Non-pharmacological Management
16. Pharmacological Therapy
17. Insulin Therapy
18. Progress Check

CONCLUSION
19. Summary


COURSE OBJECTIVES
Students completing this course should be able to:
  • List three types of microvascular diseases connected with type 2 diabetes
  • List three types of macrovascular disease connected with type 2 diabetes
  • Describe diabetic nephropathy
  • Describe diabetic neuropathy
  • Describe diabetic retinopathy
  • Describe diabetic foot
  • Explain the significance of blood glucose and blood pressure regulation in preventing clinical complications
  • Describe the guidelines for managing diabetes
  • List four components of non-pharmacological therapy for diabetes patients
  • Name the four drug classes used for the treatment of type 2 diabetes
  • Describe the mechanism of action of each drug class used for the treatment of type 2 diabetes

 

   

SeerPharma has partnered with GeneEd to now distribute courses in Major Therapeutic Areas, Clinical Research, and Biotechnology & Genetics.

 

© SeerPharma Pty Ltd 2008 | Resources | Privacy Policy